4th Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$2,030,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

18 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Medicaid Rebates Dual Eligibles S. 365: Budget Control Act of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Medicare Part D Prescription Drug Program

Contacted: Agriculture, Dept of (USDA); Navy, Dept of; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Defense, Dept of (DOD); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Energy, Dept of; Patent & Trademark Office (PTO); State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); White House Office

Bills named: S. 365 (112th), H.R. 2245 (112th), S. 296 (112th), H.R. 2112 (112th)

Clean Air and Water (quality) CAW

Climate Change Benefits of Biofuels and Bio-based Products Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biogenic Carbon Emissions Accounting

LobbyistCovered position, as disclosed
MATT CARR —
SARAH THORNTON CASWELL —
BRENT ALAN DELMONTE —
DANA MAURICE O'BRIEN —

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Navy, Dept of; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA); Defense, Dept of (DOD); Office of Science & Technology Policy (OSTP); State, Dept of (DOS); Environmental Protection Agency (EPA); Energy, Dept of

Fuel/Gas/Oil FUE

Climate Change Benefits of Biofuels and Bio-based Products Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biogenic Carbon Emissions Accounting Biofuels Next Generation Incentives : Farm Bill Reauthorization Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Fuels Standard Implementation of Energy Independence and Security Act of 2007 Regulatory Oversight Biorefineries Next Generation Incentive Tax Credits Bio-based Products Next Generation Incentives: Farm Bill Reauthorization Expansion of DOE and USDA Loan Guarantee Programs Tax Credit USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Funding for Bio-based Products H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals)

LobbyistCovered position, as disclosed
MATT CARR —
SARAH THORNTON CASWELL —
BRENT ALAN DELMONTE —
CHARLES H FRITTS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: White House Office; Energy, Dept of; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Food & Drug Administration (FDA); Navy, Dept of; Defense, Dept of (DOD); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2354 (112th), S. 847 (112th), H.R. 2219 (112th)

Homeland Security HOM

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Federal Supply Schedule Access During Emergencies Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization Act of 2011 International Biosecurity Policies Biologics and Toxins Weapons Convention

Contacted: Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); SENATE; White House Office; Food & Drug Administration (FDA); Navy, Dept of; State, Dept of (DOS); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Defense, Dept of (DOD); Energy, Dept of; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Bills named: S. 1855 (112th)

Trade (domestic/foreign) TRD

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations Discussions with EU on Animal Cloning APEC Agricultural Biotechnology Discussions EU Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property Protections for Pharmaceuticals

Contacted: Navy, Dept of; SENATE; Agriculture, Dept of (USDA); White House Office; Energy, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Defense, Dept of (DOD); State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Agriculture AGR

USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Biomass Crop Assistance Program Funding H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Farm Bill Reauthorization EPA Regulations on Agricultural Biotechnology EPA Notice on PIP Data Requirements Reauthorization and Implementation of Pesticide Registration Improvement Act Biotechnology Stewardship International Regulatory Synchronization Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2011 H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon Export Registrations for Products with Expired Patents Labeling of Genetically Engineered Crops U.S. Government Policy TransPacific Partnership Sanitary and Phytosanitary Issues Adventitious Presence (Low Level Presence) U.S. Low Level Presence Policy Funding for the USDA (Office of General Counsel , Biotechnologies Regulatory Services (BRS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service) H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations Discussions with EU on Animal Cloning APEC Agricultural Biotechnology Discussions EU Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions

LobbyistCovered position, as disclosed
AB BASU —
JOSEPH DAMOND New —
BRENT ALAN DELMONTE —
TOM DILENGE —
DAVID EDWARDS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); State, Dept of (DOS); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Patent & Trademark Office (PTO); Energy, Dept of; Health & Human Services, Dept of (HHS); Navy, Dept of; Office of Science & Technology Policy (OSTP); Defense, Dept of (DOD)

Bills named: S. 1717 (112th), H.R. 2112 (112th)

Taxation/Internal Revenue Code TAX

Biorefineries Next Generation Incentive Tax Credits Bio-based Products Tax Credit Therapeutic Discovery Project Tax Credit Extension Biofuels Investment Tax Credit Options Biofuels Production Tax Credit Modification for Algae-based Biofuels Biofuels Production Tax Credit Extension Research & Development Tax Credit Extension H.R. 942: American Research and Competitiveness Act of 2011 S. 1577: Greater Research Opportunities With Tax Help Act of 2011 Capital Formation Investment Incentives Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Navy, Dept of; Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Agriculture, Dept of (USDA); White House Office; Energy, Dept of

Bills named: H.R. 942 (112th), S. 1577 (112th)

Copyright/Patent/Trademark CPT

Patent Reform Implementation of H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions China Issues Finland Issues Russia Issues Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The America Invents Act of 2011 Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Domestic Manufacturing Requirement International IP Patent Law Harmonization TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); State, Dept of (DOS); Environmental Protection Agency (EPA); Energy, Dept of; Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); White House Office; Navy, Dept of

Bills named: H.R. 1249 (112th)

Health Issues HCR

TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Federal Supply Schedule Access During Emergencies Expanded Access to Experimental Products Medicaid Rebates Dual Eligibles S 365: Budget Control Act of 2011 Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Part D Prescription Drug Program International Biosecurity Policies Biologics and Toxins Weapons Convention

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Navy, Dept of; Environmental Protection Agency (EPA); Energy, Dept of; Office of Science & Technology Policy (OSTP); Defense, Dept of (DOD); White House Office; State, Dept of (DOS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: S. 1855 (112th), H.R. 3590 (112th), S. 296 (112th), H.R. 2112 (112th), H.R. 2245 (112th)

Small Business SMB

Shareholder Reporting Threshold S. 1824/H.R. 2167: Private Company Flexibility and Growth Act of 2011 Small Business Innovation and Research (SBIR) Program Reauthorization S.493: SBIR/STTR Reauthorization Act of 2011 H.R. 1425: Creating Jobs Through Small Business Innovation Act of 2011 H.R. 1540: National Defense Authorization Act for FY 2012 Sarbanes Oxley Section 404 (b) H.R. 3213: Small Company Job Growth and Regulatory Relief Act of 2011 S. 1933/H.R. 3606: Reopening American Capital Markets to Emerging Growth Companies Act of 2011 Therapeutic Discovery Project Tax Credit Extension Capital Formation Investment Incentives Expansion of Exemption Under SEC Regulation A S. 1544/H.R. 1070: The Small Company Capital Formation Act of 2011 Reform of SEC Regulation D S. 1831/H.R. 2940: Access to Capital for Job Creators Act of 2011

Contacted: U.S. Trade Representative (USTR); Defense, Dept of (DOD); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Energy, Dept of; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Navy, Dept of; State, Dept of (DOS)

Bills named: S. 1831 (112th), S. 1544 (112th), H.R. 1540 (112th), H.R. 2167 (112th), H.R. 2940 (112th), S. 1824 (112th), S. 1933 (112th), H.R. 1425 (112th), H.R. 1070 (112th), H.R. 3606 (112th), H.R. 3213 (112th), S. 493 (112th)

Medicare/Medicaid MMM

Medicaid Rebates Dual Eligibles S. 365: Budget Control Act of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program

Contacted: Defense, Dept of (DOD); SENATE; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Navy, Dept of; HOUSE OF REPRESENTATIVES; White House Office; Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Energy, Dept of; U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS)

Bills named: S. 365 (112th)

Budget/Appropriations BUD

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Funding for the USDA (Office of General Counsel , Biotechnologies Regulatory Services (BRS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service) H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H..R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Biofuels H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Funding for Bio-based Products H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Funding for Biomass Crop Assistance Program H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012

Contacted: U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Defense, Dept of (DOD); State, Dept of (DOS); Agriculture, Dept of (USDA); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Navy, Dept of; Energy, Dept of; White House Office; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA)

Bills named: H.R. 2219 (112th), H.R. 2354 (112th), H.R. 2112 (112th)

Consumer Issues/Safety/Products CSP

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012 H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Labeling of Genetically Engineered Crops U.S. Government Policy Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); SENATE; Office of Science & Technology Policy (OSTP); Defense, Dept of (DOD); Natl Institutes of Health (NIH); State, Dept of (DOS); Navy, Dept of; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Energy, Dept of; White House Office

Bills named: S. 1717 (112th), S. 296 (112th), H.R. 2245 (112th), H.R. 2112 (112th)

Energy/Nuclear ENG

Climate Change Benefits of Biofuels and Bio-based Products Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biogenic Carbon Emissions Accounting Biofuels Next Generation Incentives : Farm Bill Reauthorization Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Fuels Standard Implementation of Energy Independence and Security Act of 2007 Regulatory Oversight Biorefineries Next Generation Incentive Tax Credits Bio-based Products Next Generation Incentives: Farm Bill Reauthorization Expansion of DOE and USDA Loan Guarantee Programs Tax Credit USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Funding for Bio-based Products H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals)

LobbyistCovered position, as disclosed
MATT CARR —
SARAH THORNTON CASWELL —
BRENT ALAN DELMONTE —
CHARLES H FRITTS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Energy, Dept of; Environmental Protection Agency (EPA); State, Dept of (DOS); Agriculture, Dept of (USDA); Navy, Dept of; White House Office; Office of Science & Technology Policy (OSTP)

Bills named: H.R. 2219 (112th), S. 847 (112th), H.R. 2354 (112th)

Food Industry (safety, labeling, etc.) FOO

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2011 H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon Labeling of Genetically Engineered Crops U.S. Government Policy

LobbyistCovered position, as disclosed
AB BASU —
BRENT ALAN DELMONTE —
DAVID EDWARDS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —

Contacted: Defense, Dept of (DOD); State, Dept of (DOS); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Energy, Dept of; Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); White House Office; Navy, Dept of; Food & Drug Administration (FDA)

Bills named: S. 1717 (112th), H.R. 2112 (112th)

Animals ANI

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012 H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon

LobbyistCovered position, as disclosed
AB BASU —
BRENT ALAN DELMONTE —
DAVID EDWARDS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —

Contacted: Office of Science & Technology Policy (OSTP); Navy, Dept of; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); SENATE; Patent & Trademark Office (PTO); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Energy, Dept of; State, Dept of (DOS); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); White House Office

Bills named: H.R. 2112 (112th), S. 1717 (112th)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Rare Pediatric & Tropical Disease Drug Development Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011

Contacted: Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Energy, Dept of; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); White House Office; Navy, Dept of; U.S. Trade Representative (USTR)

Bills named: S. 1855 (112th)

Science/Technology SCI

Research & Development Tax Credit Extension H.R. 942: American Research and Competitiveness Act of 2011 S. 1577: Greater Research Opportunities With Tax Help Act of 2011 Small Business Innovation and Research (SBIR) Program Reauthorization S.493: SBIR/STTR Reauthorization Act of 2011 H.R. 1425: Creating Jobs Through Small Business Innovation Act of 2011 H.R. 1540: National Defense Authorization Act for FY 2012

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS —
MATTHEW SCHUMAKER —

Contacted: Health & Human Services, Dept of (HHS); State, Dept of (DOS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Defense, Dept of (DOD); SENATE; Energy, Dept of; Agriculture, Dept of (USDA); Navy, Dept of; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); White House Office

Bills named: S. 1577 (112th), H.R. 1425 (112th), H.R. 942 (112th), H.R. 1540 (112th), S. 493 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.